We have all become more educated on coronavirus in general over the past few years whether we wanted to be or not. However, dairy producers have been dealing with health issues from coronavirus in their herds for quite some time.

With the fall calf prices setting up to be some of the highest since 2014, stocker and feedlot operations may be forced to purchase cattle that are higher risk than they are comfortable with when it comes to the chance of bovine respiratory disease (BRD) in order to fill pastures and pens.

One study done in 11 herds who had a history of BRD found M. bovis in 20% of the pre-weaned calves tested. It was the only bacteria associated with lung lesions seen on ultrasound, clinical scores of respiratory disease and lower average daily gains. 

As the cattle industry continues to advance and improve antibiotic stewardship practices, producers and veterinarians are reevaluating their approach to metaphylaxis, the administration of antibiotics on arrival to calves at high risk of bovine respiratory disease (BRD).

When it comes to bovine respiratory disease, it can be extremely difficult to determine if a sick calf may need a second round of treatment or if the antibiotic should be allowed a few more days to help treat the infection.

With the arrival of cold weather comes the increased threat of bovine respiratory disease (BRD), or calfhood pneumonia, that often comes with it. Having a plan to prevent, diagnose and treat this common yet serious disease is key to help protect your dairy’s future.

If bovine respiratory disease (BRD) is a challenge on your dairy, you’re not alone. BRD remains the number two killer of pre-weaned calves and is the primary cause of death in weaned calves.

Mostly known for its use in reproductive work – confirming pregnancy, looking at fetal gender, fetal age and ovaries – ultrasound technology has many uses in the beef industry.

Most producers know that calfhood pneumonia, or bovine respiratory disease (BRD), is one of the leading health concerns impacting calves on even the best-managed dairies. The disease challenges young calves face when they are most vulnerable can have lifelong productivity and profitability implications.